Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 19.16
+0.12 (0.63%)
Feb 3, 2026, 3:04 PM CST
SHE:300119 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 414.26 | 300.72 | 453.59 | 346.7 | 412.78 | 398.2 |
Depreciation & Amortization | 203.28 | 203.28 | 146.98 | 115.57 | 91.57 | 95.75 |
Other Amortization | 2.39 | 2.39 | 0.94 | 0.59 | 0.35 | 0.88 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -114.09 | 0.01 | -0.1 | 0.02 |
Asset Writedown & Restructuring Costs | 0.14 | 0.14 | 0.47 | 0.11 | 9.1 | 1.34 |
Loss (Gain) From Sale of Investments | 1.56 | 1.56 | -76.41 | -55.43 | -132.26 | -118.26 |
Provision & Write-off of Bad Debts | 16.57 | 16.57 | 26.85 | 19.7 | 17.93 | 29.36 |
Other Operating Activities | -200.5 | 84.62 | 87.52 | 54.07 | 47.91 | 70.3 |
Change in Accounts Receivable | -75.82 | -75.82 | -268.49 | -180.5 | -178.29 | -101.74 |
Change in Inventory | -22.63 | -22.63 | -70.22 | -6.11 | 2.69 | -100.82 |
Change in Accounts Payable | 228.96 | 228.96 | 189.6 | 87.54 | 70.71 | 47.95 |
Change in Other Net Operating Assets | -4.68 | -4.68 | 11.22 | 3.77 | 20.64 | 42.87 |
Operating Cash Flow | 563.97 | 735.55 | 410.13 | 389.49 | 382.63 | 388.44 |
Operating Cash Flow Growth | -4.51% | 79.34% | 5.30% | 1.79% | -1.50% | 1.26% |
Capital Expenditures | -151.94 | -185.34 | -251.66 | -372.43 | -305.88 | -259.17 |
Sale of Property, Plant & Equipment | 0.19 | 0.06 | 159.73 | 0.11 | 3.13 | 0.17 |
Cash Acquisitions | -170.55 | -240.01 | -133.05 | - | - | - |
Divestitures | 92.46 | - | - | - | 12.82 | - |
Investment in Securities | 12.02 | -101.37 | -118.21 | -909.43 | -349.14 | -8.06 |
Other Investing Activities | 95.61 | 74.98 | 41.88 | 37.02 | 12.01 | 23.99 |
Investing Cash Flow | -122.21 | -451.67 | -301.31 | -1,245 | -627.06 | -243.07 |
Short-Term Debt Issued | - | 16.99 | 17.5 | 32.35 | 33.4 | 84.26 |
Long-Term Debt Issued | - | 1,029 | 729.71 | 1,032 | 653.95 | 758.56 |
Total Debt Issued | 1,196 | 1,046 | 747.21 | 1,064 | 687.35 | 842.82 |
Long-Term Debt Repaid | - | -810.39 | -750.78 | -888.74 | -527.39 | -854.44 |
Total Debt Repaid | -1,273 | -810.39 | -750.78 | -888.74 | -527.39 | -854.44 |
Net Debt Issued (Repaid) | -77.74 | 235.63 | -3.57 | 175.35 | 159.96 | -11.62 |
Issuance of Common Stock | 7.2 | 7.2 | 29.2 | 39.92 | 1,325 | - |
Repurchase of Common Stock | -115.07 | -115.07 | -44.93 | -1.79 | - | -0.92 |
Common Dividends Paid | -169.1 | -215.78 | -163.29 | -190.4 | -181.58 | -115.38 |
Other Financing Activities | 48.81 | -45.25 | 12.41 | -71.42 | -43.36 | -41.94 |
Financing Cash Flow | -305.9 | -133.28 | -170.18 | -48.35 | 1,260 | -169.86 |
Foreign Exchange Rate Adjustments | 0.47 | 0.66 | 0.06 | 0.04 | - | - |
Net Cash Flow | 136.33 | 151.26 | -61.29 | -903.55 | 1,016 | -24.49 |
Free Cash Flow | 412.03 | 550.21 | 158.47 | 17.05 | 76.75 | 129.27 |
Free Cash Flow Growth | 10.80% | 247.21% | 829.28% | -77.78% | -40.63% | -16.00% |
Free Cash Flow Margin | 12.22% | 17.92% | 5.85% | 0.82% | 3.82% | 6.46% |
Free Cash Flow Per Share | 0.90 | 1.20 | 0.34 | 0.04 | 0.19 | 0.33 |
Cash Interest Paid | 0.88 | 0.88 | - | 0.19 | 1.63 | - |
Cash Income Tax Paid | 160.53 | 158.98 | 152.64 | 87.71 | 108.6 | 112.81 |
Levered Free Cash Flow | 40.56 | 584.55 | 15.62 | -51.25 | -132.66 | -16.06 |
Unlevered Free Cash Flow | 62.85 | 604.06 | 31.51 | -33.48 | -117.77 | 0.93 |
Change in Working Capital | 126.24 | 126.24 | -115.72 | -91.83 | -64.66 | -89.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.